2023 ICD-10-CM Diagnosis Code B44

Aspergillosis

    2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
  • B44 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2023 edition of ICD-10-CM B44 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of B44 - other international versions of ICD-10 B44 may differ.
Includes
Includes Help
"Includes" further defines, or give examples of, the content of the code or category.
  • aspergilloma
The following code(s) above B44 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to B44:
  • A00-B99
    2023 ICD-10-CM Range A00-B99

    Certain infectious and parasitic diseases

    Includes
    • diseases generally recognized as communicable or transmissible
    Type 1 Excludes
    • certain localized infections - see body system-related chapters
    Type 2 Excludes
    • carrier or suspected carrier of infectious disease (Z22.-)
    • infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium (O98.-)
    • infectious and parasitic diseases specific to the perinatal period (P35-P39)
    • influenza and other acute respiratory infections (J00-J22)
    Use Additional
    • code to identify resistance to antimicrobial drugs (Z16.-)
    Certain infectious and parasitic diseases
  • B35-B49
    2023 ICD-10-CM Range B35-B49

    Mycoses

    Type 2 Excludes
    • hypersensitivity pneumonitis due to organic dust (J67.-)
    • mycosis fungoides (C84.0-)
    Mycoses
Clinical Information
  • An infectious fungal disease that occurs most often in the skin, ears, nasal sinuses, and lungs of people with suppressed immune systems.
  • Aspergillosis is a disease caused by a fungus (or mold) that is very common in the environment. There are different kinds of aspergillosis. One kind is allergic bronchopulmonary aspergillosis (also called abpa). Symptoms of abpa include wheezing and coughing. Abpa can affect healthy people but it is most common in people with asthma or cystic fibrosis.another kind is invasive aspergillosis, which invades and damages tissues in the body. It usually affects the lungs, but it can also cause infection in other organs and spread throughout the body. It affects people who have immune system problems, such as people who have had a transplant, are taking high doses of steroids, or getting chemotherapy for some cancers.your doctor might do a variety of tests to make the diagnosis, including a chest x-ray, ct scan of the lungs, or examining tissues for signs of the fungus. Treatment is with antifungal drugs. Centers for Disease Control and Prevention.
  • Disease condition caused by species of aspergillus and marked by inflammatory granulomatous lesions in the skin, ear, orbit, nasal sinuses, lungs, and sometimes in the bones and meninges.
  • Infections with fungi of the genus aspergillus.
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
Code annotations containing back-references to B44:
  • Type 2 Excludes: J82
    ICD-10-CM Diagnosis Code J82

    Pulmonary eosinophilia, not elsewhere classified

      2016 2017 2018 2019 2020 2021 - Converted to Parent Code 2022 2023 Non-Billable/Non-Specific Code
    Type 2 Excludes
    • pulmonary eosinophilia due to aspergillosis (B44.-)
    • pulmonary eosinophilia due to drugs (J70.2-J70.4)
    • pulmonary eosinophilia due to specified parasitic infection (B50-B83)
    • pulmonary eosinophilia due to systemic connective tissue disorders (M30-M36)
    • pulmonary infiltrate NOS (R91.8)
ICD-10-CM Codes Adjacent To B44
B42.81 Cerebral sporotrichosis
B42.82 Sporotrichosis arthritis
B42.89 Other forms of sporotrichosis
B42.9 Sporotrichosis, unspecified
B43 Chromomycosis and pheomycotic abscess
B43.0 Cutaneous chromomycosis
B43.1 Pheomycotic brain abscess
B43.2 Subcutaneous pheomycotic abscess and cyst
B43.8 Other forms of chromomycosis
B43.9 Chromomycosis, unspecified
B44 Aspergillosis
B44.0 Invasive pulmonary aspergillosis
B44.1 Other pulmonary aspergillosis
B44.2 Tonsillar aspergillosis
B44.7 Disseminated aspergillosis
B44.8 Other forms of aspergillosis
B44.81 Allergic bronchopulmonary aspergillosis
B44.89 Other forms of aspergillosis
B44.9 Aspergillosis, unspecified
B45 Cryptococcosis
B45.0 Pulmonary cryptococcosis

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.